Coumarin embryopathy in an extremely low birth weight infant associated with neonatal hepatitis and ocular malformations

European Journal of Pediatrics

Volumn 165, Issue 6, 2006, Pages 358-360

  Hetzel, Patrick G ^a   Glanzmann, René ^a   Hasler, Pascal W ^b   Ladewick, Ariane ^c   Bührer, Christoph ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

Author keywords

Congenital cataract; Coumarin embryopathy; Neonatal hepatitis; Persistent hyperplastic primary vitreous

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; CEFTAZIDIME; DALTEPARIN; PHENPROCOUMON;

ANTERIOR EYE SEGMENT; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CASE REPORT; CONGENITAL CATARACT; CORNEA OPACITY; EMBRYOPATHY; EXTREMELY LOW BIRTH WEIGHT; EYE MALFORMATION; FEMALE; HEART VALVE PROSTHESIS; HUMAN; HYPERBILIRUBINEMIA; HYPOGLYCEMIA; INFANT; LIVER DISEASE; LIVER DYSFUNCTION; MIDFACE HYPOPLASIA; NEWBORN HEPATITIS; PERSISTENT HYPERPLASTIC PRIMARY VITREOUS; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTICOAGULANTS; CORNEAL OPACITY; DRUG-INDUCED LIVER INJURY; ENDOCARDITIS, BACTERIAL; EYE ABNORMALITIES; FACE; FEMALE; FETUS; HEART VALVE PROSTHESIS; HEPATITIS, TOXIC; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; PHENPROCOUMON; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; THROMBOEMBOLISM;

EID: 33646470693     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-005-0064-1     Document Type: Article

References (22)

1. ACOG committee opinion (1999) Anticoagulation with low molecular weight heparin during pregnancy. Int J Gyn Obstet 65:89-90
2. Bates SM, Greer IA, Hirsh J, Ginsberg JS (2004) Use of antithrombotic agents during pregnancy: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Evidence based guidelines. Chest 126:6278-6448
3. Cauli C, Fenu L, Perra A, Marongiu F (2004) Amoxicillin-clavulanic acid and oral anticoagulants: a possible dangerous association. Ann Ital Med Int 19:276-279
4. Chan WS, Anand S, Ginsberg JS (2000) Anticoagulation of pregnant women with mechanical heart valves a systematic review of the literature. Arch Intern Med 160:191-196
5. de Man RA (1993) Phenprocoumon-induced liver failure. Neth J Med 43:91
6. de Man RA, Wilson JPH, Schalm SW, ten Kate FJW, Van Leer E (1990) Phenprocoumon-induced hepatits mimicking non-A, non-B hepatitis. J Hepatol 11:318-321
7. DiSaia PJ (1966) Pregnancy and delivery of a patient with a Starr-Edwards mitral valve prosthesis. Obstet Gynecol 28:469-472
8. Ginsberg JS (1999) Thromboembolism and pregnancy. Throm Haemost 82:620-625
9. Ginsberg JS, Kowalchuk G, Hirsh J (1989) Risk to the fetus of anticoagulant therapy during pregnancy. Arch Intern Med 149:2233-2236
10. Gresser U (2001) Amoxicillin-clavulanic acid therapy may be associated with severe side effects - review of the literature. Eur J Med Res 6:139-149
11. Hautekeete M, Holvoet J, Hubens H (1995) Cytolytic hepatitis related to the oral anticoagulant phenprocoumon. Gastroenterol Clin Biol 19:223-224
12. Höhler T, Schnütgen M, Helmreich-Becker I, Mayet WJ, Mayer zum Bueschenfelde KH (1994) Drug-induced hepatitis: a rare complication of oral anticoagulants. J Hepatol 21:447-449
13. Kaplan LC (1985) Congenital Dandy Walker malformation associated with first trimester warfarin: a case report and literature review. Teratology 32:333-337
14. Lee WM (1995) Drug-induced hepatotoxicity. N Engl J Med 333:1118-1127
15. Montalescot G, Polle V, Collet JP (2000) Low-molecular-weight heparin after mechanical heart valve replacement. Circulation 101:1083-8106
16. Mix H, Wagner S, Böker K, Gloger S, Oldhafer KJ, Behrend M, Flemming P, Mann MP (1999) Subacute liver failure induced by phenprocoumon treatment. Digestion 60:579-582
17. Sanson BJ, Lensing AWA, Prins MH (1999) The use of low-molecular-weight heparin in pregnancy. Thromb Haemost 81:668-672
18. Schimanski CC, Burg J, Möhler K, Höhler T, Kanzler S, Otto G, Galle PR, Lohse AW (2004) Phenprocoumon-induced liver diseases range from mild acute hepatitis to (sub-) acute liver failure. J Hepatol 41:67-74
19. Slagboom G, Loeliger EA (1980) Coumarin-associated hepatitis. Arch Intern Med 140:1028-1029
20. Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology (2003) Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 24:761-781
21. Van Driel D, Wesseling J, Sauer PJJ, Touwen BCL, Van Der Veer E, Heymans HSA (2002) Teratogen update: fetal effects after, in utero exposure to coumarins, overview of cases, follow-up findings, and pathogenesis. Teratology 66:127-140
22. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M (1999) Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 33:1637-1641